Order by phone 0800-177-7778
Intercure logo

Press Releases Archive

2005 Press Releases

Non-drug Hypertension Treatment Device Presented at the British Hypertension Society Annual Meeting

Sep 27, 2005

White-Coat Effect is Virtually Eliminated Using a Non-drug Hypertension Treatment Device

May 16, 2005

InterCure Raises $3 Million in First Closing of Series C Financing Led By Major Japanese Venture Capital Firm

April 13, 2005

Frost & Sullivan Recognizes InterCure for Hypertension Treatment Technology Innovation

March 16, 2005

2004 Press Releases

Interactive Breathing Device Found Effective in Lowering High Systolic Blood Pressure

October 12, 2004

Non-Drug Treatment Device Delivers Sustained Blood Pressure Reductions Within 3-4 Weeks in the Home Setting

April 21, 2004

Korean FDA Approves Breakthrough Therapeutic Breathing Device To Lower Blood Pressure

April 7, 2004

2003 Press Releases

Respiratory-Pacing Device Found Beneficial in Heart Failure

Sept. 22, 2003

Non-drug treatment for hypertension found effective in hard-to-control refractory hypertensives

June 30, 2003

Non-drug, treatment for hypertension gets further physiological backing in American Heart Association's textbook

May 7, 2003

Il Yang Pharm Named As Intercure's Exclusive Distributor In Korea

February 4, 2003

2002 Press Releases

InterCure Appoints Exclusive Distributor In Israel

November 26, 2002

FDA Clears Breakthrough Therapeutic Breathing Device To Lower Blood Pressure

July 17, 2002

Positive Trial Results Provide Additional Support For RESPERATE™, New Non-Drug Treatment For High Blood Pressure

May 15 , 2002

2001 Press Releases

Italian Study Further Validates Use of RESPeRATE™ For Adjunctive Treatment of Hypertension

November 12, 2001

InterCure Raises $4.5 Million in Second Round Financing Led by Medica Venture Partners

October 29, 2001

Michael Weber M.D., American Society of Hypertensions' Immediate Past President Joins InterCure Scientific Advisory Board

October 2, 2001

InterCure Scientific Advisory Board Convenes to Review Company's RESPeRATE Medical Device for Hypertension

July 23, 2001

InterCure Names Paul Sheils, Former CEO of Medscape, As CEO to Head Medical Technology Innovator

May 14, 2001

2000 Press Releases

First Prescription-Only, Non-Drug Option for High-Blood Pressure Now Available

December 21, 2000

InterCure Selects SoftWatch SRS 2.0 Platform to Power RESPeRATE™ for Lower Blood Pressure

August 9, 2000

InterCure Receives Market Clearance for RESPeRATE™ Device as Adjunctive Treatment for High Blood Pressure

May 18, 2000

InterCure Receives a $5.4 Million Investment From Manhattan-Based VC Funds...

March 29, 2000

« Return to current press releases

Doctors on RESPeRATE

photo of Dr. Rowena

"My patients thank me for recommending RESPeRATE and see real results."

  • Dr. Rowena Sobczyk
    Family Physician, Author of the book "My Body, My Health"
photo of Dr. Marek

"RESPeRATE allows my patients to have more of a role in their care."

  • Dr. Joseph Marek
    Midwest Heart Specialists
    Downers Grove, IIlinois
photo of Dr. Elliot

"Our clinical study concluded that RESPeRATE is easy to use, did not have any side effects & delivered a significant blood pressure reduction."

  • Dr. William Elliot
    Rush University
    Chicago, Illinois

Watch video »